AMARILLO, TX – Yesterday, a federal judge ruled that Missouri, Kansas, and Idaho can move forward with their lawsuit against the U.S. Food and Drug Administration (FDA) that could restrict future access to the abortion drug Mifepristone. The states argue that the FDA’s deregulation of Mifepristone allows the drug to cross their borders and undermine their abortion laws. The ruling denied the FDA’s request to dismiss the case and granted the states more time to amend and strengthen their complaint.